Takahiro Sugimoto

This inventor holds 36 USPTO granted patents and 10 published patent applications and 14 EPO patents, primarily in Heterocyclic Compounds. Top assignees: Takeda Pharmaceutical Company Limited, Toshiba Memory Corporation. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takahiro Sugimoto. Retrieved from https://idiyas.com/inventor/takahiro-sugimoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 36 (Patent Applications = 10)

% Patents Active = 97.2

EPO Patents = 14 (Patent Applications = 10)

Average Co-Inventor Count = 7.2

ph-index = 6

Forward Citations = 132(Granted Patents)

Location History:

Fujisawa, JP (2018)
Mie, JP (2021)
Kanagawa, JP (2016 - 2024)

Company Filing History:

34 out of 1,226

Takeda Pharmaceutical Company Limited

patents

2 out of 2,955

Toshiba Memory Corporation

patents

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Heterocyclic Compound

Cholinergic Receptor

Alzheimer's Disease

Positive Allosteric Modulator

Nitrogen-Containing

Bicyclic Compound

Pyrrole Ring

Sleepiness Treatment

Semiconductor Device

Memory Device

Sulfonamide Derivatives

Isoindoline Derivatives

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662453 - Heterocyclic compound and use thereof (2026-06-23),

2. 12421188 - Heterocyclic compound and use thereof (2025-09-23),

3. 12415782 - Heterocyclic compound and use thereof (2025-09-16),

4. 12404237 - Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1'-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives (2025-09-02),

5. 12358879 - Heterocyclic compound (2025-07-15),

6. 12091410 - Heterocyclic compound (2024-09-17),

7. 12071434 - Heterocyclic compound (2024-08-27),

8. 11655241 - Heterocyclic compound and use thereof (2023-05-23),

9. 11440883 - Heterocyclic compound and use thereof (2022-09-13),

10. 11319286 - Heterocyclic compound and application thereof (2022-05-03),

11. 11164639 - Semiconductor memory device (2021-11-02),

12. 11018217 - Semiconductor device and method for manufacturing the same (2021-05-25),

13. 10899752 - 2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor (2021-01-26),

14. 10865200 - Nitrogen-containing heterocyclic compound (2020-12-15),

15. 10584097 - Heterocyclic compound and use thereof (2020-03-10),

Title: Unveiling the Inventive Journey of Takahiro Sugimoto

Introduction:

Takahiro Sugimoto, a prolific inventor hailing from Kanagawa, Japan, has made significant contributions to the field of pharmaceuticals and medical treatments. With an impressive portfolio of 29 patents, Sugimoto's innovative work continues to shape the landscape of healthcare and pharmacology.

Latest Patents:

Among his recent patents is the groundbreaking discovery of a heterocyclic compound with orexin type 2 receptor agonist activity. This compound, represented by the formula (I), exhibits promising potential as an agent for the prophylaxis and treatment of narcolepsy, offering new hope for individuals suffering from this neurological disorder.

Career Highlights:

Sugimoto's professional journey has seen him lend his expertise to esteemed companies such as Takeda Pharmaceutical Company Limited and Toshiba Memory Corporation. Through his tenure at these organizations, Sugimoto has honed his skills and expanded his knowledge, paving the way for groundbreaking inventions in the realm of pharmaceuticals.

Collaborations:

Throughout his career, Takahiro Sugimoto has collaborated closely with talented individuals such as Hiroki Sakamoto and Makoto Kamata. Together, these innovators have synergized their talents and expertise to drive forward cutting-edge research and development initiatives, fostering a culture of innovation and discovery.

Conclusion:

In conclusion, Takahiro Sugimoto stands as a beacon of innovation in the field of pharmaceuticals, with his myriad patents and pioneering discoveries serving as a testament to his unwavering dedication to advancing scientific knowledge and improving healthcare outcomes. His inventive spirit and collaborative ethos continue to inspire future generations of inventors and researchers on the path to transformative discoveries in the world of medicine and beyond.

Profile summary based on public USPTO records.